Form 4: SurgePays Director Richard Schurfeld Reports Warrant Sales and Common Stock Purchase
SEC Form 4 Filing
Richard Schurfeld, a director at SurgePays, Inc., reported the sale of warrants and the purchase of common stock in a recent SEC filing.
Summary
- On September 9, 2024, Richard Schurfeld sold 100 warrants at $0.03 each.
- On September 11, 2024, Schurfeld sold 22,900 warrants at $0.0092 each.
- On September 13, 2024, Schurfeld purchased 1,800 shares of common stock at $1.50 per share, bringing his total holdings to 44,001 shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as the document primarily reports transactions without providing explicit positive or negative outlook.
Positives
- The director's purchase of 1,800 shares of common stock could be interpreted as a positive signal.
Negatives
- The sale of warrants by a director could be viewed negatively by investors.
Risks
- Insider trading activity, even if legal, can sometimes create uncertainty among investors.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common among publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company's prospects.
Stakeholder Impact
- Shareholders may react to the reported transactions, potentially influencing the stock price.
Key Dates
| Date | Description |
|---|---|
| 09/09/2024 | Sale of 100 warrants at $0.03 each. |
| 09/11/2024 | Sale of 22,900 warrants at $0.0092 each. |
| 09/13/2024 | Purchase of 1,800 shares of common stock at $1.50 per share. |
| 09/20/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.